⚡ Our October issue is live! Featuring checkpoint inhibitor therapy for #LynchSyndrome, senolytic treatment for #Alzheimersdisease and studies on #diabetes, #PTSD, #autism and #NASH, as well as an editorial on weight-loss drugs, News, Opinion and more...
https://t.co/Waustr4oBm
Join us for a comprehensive update on clinical #cancergenetics w/ leading experts from @MSKCancerCenter. We'll explore the latest advancements in cancer #genomics & how genetic testing is transforming patient care. Learn more: https://t.co/oCkkr1gazv
#MSKHereditaryCancerGentics
The Clinical Genetics Service at MSK is hosting the 13th Annual #LynchSyndrome Educational Workshop on 4/9. Join Dr. @StadlerZsofia, Dr. @YingLiu88, & more experts as they discuss updates in cancer surveillance, prevention, & research. Register here ➡️ https://t.co/gYCxueI0Ce
🚨 The Clinical Genetics Service at @MSKCancerCenter is hosting a patient symposium focusing on #ATM & #PALB2 🧬
🗓️ 11/14
⌚️6:30 PM ET
📍Zoom
All are cordially invited. Please share with your colleagues & patients!
Register: https://t.co/6CtuGXuhkt
⚡ Our October issue is live! Featuring checkpoint inhibitor therapy for #LynchSyndrome, senolytic treatment for #Alzheimersdisease and studies on #diabetes, #PTSD, #autism and #NASH, as well as an editorial on weight-loss drugs, News, Opinion and more...
https://t.co/Waustr4oBm
Congrats @EileenMOReilly ! So nice to be here in-person to hear your inspiring talk and to see you receive this prestigious #Burkitt medal- so well-deserved!
How do the changes in general population colonoscopy recs alter what we recommend for patients with moderate penetrance germline variants? 🤔Here are some thoughts! 💭
📣Shout out to my colleague and genetic counselor Kelsey Breen for leading this effort and all the co-authors!
🙏Many thanks to @CavestroGM for organizing the #MilanEOCRC#DIRECt meeting & the int’l #HereditaryGICancer community for their time & valuable contribution.
We're pleased to support this crucial effort, working together to improve outcomes for individuals with #EOCRC globally
Very proud of our study published in @NEJM. 100% clinical complete response with dostarlimab alone in mismatch repair-deficient locally advanced #RectalCancer. No radiation or surgery! @ASCO#ASCO22@MSKCancerCenter https://t.co/sZypoHBtj7